|
|
News Breaks | | | | November 19, 2012 | | 08:15 EDT |  | CGEN | Compugen announces $15M funding agreement for Korean subsidiary
Compugen announced the signing of an agreement with a private U.S.-based investment company pursuant to which up to $15M in milestone related equity financing will be made available to Keddem Bioscience Ltd., currently a wholly owned subsidiary of Compugen. This financing will be used to further develop and commercialize a unique technology platform that has been designed to consistently enable the discovery of small molecule modulators for potentially any given protein target. Under the agreement, the new investor will obtain a majority equity interest in Keddem, with Compugen maintaining a minority interest and certain future preferential access rights to utilize the Keddem technology with Compugen discovered drug targets. | |
|
News For CGEN From The Last 14 Days Check below for free stories on CGEN the last two weeks. |
|
|
| June 10, 2013 | | 07:20 EDT |  | CGEN | Biomed to host a conference
 Subscribe for More Information | |
|
|
|
|
|
|
